Back
Can-Fite BioPharma Ltd. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
10
CANF
Can-Fite BioPharma Ltd.
Last Price:
$0.33
Seasonality Move:
-12.9%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCan-Fite BioPharma Ltd. Stock Forecast
-
Is Can-Fite BioPharma Ltd. Stock Undervalued?The current Can-Fite BioPharma Ltd. [CANF] share price is $0.34. The Score for CANF is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
-
CANF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Can-Fite BioPharma Ltd. Stock Go Up Next Year?
Data Unavailable
Can-Fite BioPharma Ltd. Stock Rating
Data Unavailable
Can-Fite BioPharma Ltd. Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
canfite.com
52-Week Data
52-Week High:
2.33
52-Week Low:
0.28
Prediction Charts
Market Cap:
5.3M
Price in USD:
0.34
Volume:
1.2M
Beta:
1.46
Technical Analysis
SMA50:
0.46
SMA100:
0.59
SMA200:
0.93
52-Wk Change:
-78.68%
Stock Predictions
-
Is Can-Fite BioPharma Ltd. stock public?Yes, Can-Fite BioPharma Ltd. is a publicly traded company.
-
What is the Can-Fite BioPharma Ltd. stock quote today?The Can-Fite BioPharma Ltd. stock price is 0.34 USD today.
-
How to buy Can-Fite BioPharma Ltd. stock online?You can buy Can-Fite BioPharma Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 0.37 | 0.37 | 0.39 | 0.36 |
| Nov-17 | 0.37 | 0.36 | 0.38 | 0.35 |
| Nov-18 | 0.55 | 0.38 | 0.62 | 0.38 |
| Nov-19 | 0.35 | 0.33 | 0.35 | 0.30 |
| Nov-20 | 0.33 | 0.31 | 0.35 | 0.30 |
| Nov-21 | 0.31 | 0.29 | 0.31 | 0.28 |
| Nov-24 | 0.30 | 0.33 | 0.36 | 0.29 |
| Nov-25 | 0.32 | 0.34 | 0.34 | 0.30 |
| Nov-26 | 0.34 | 0.34 | 0.36 | 0.32 |
| Nov-28 | 0.34 | 0.35 | 0.36 | 0.34 |
| Dec-1 | 0.35 | 0.39 | 0.39 | 0.35 |
| Dec-2 | 0.39 | 0.37 | 0.39 | 0.34 |
| Dec-3 | 0.36 | 0.34 | 0.37 | 0.34 |
| Dec-4 | 0.33 | 0.34 | 0.35 | 0.33 |
Can-Fite BioPharma Ltd. Earnings
Data Unavailable
Can-Fite BioPharma Ltd. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.00 per share.
* Can-Fite BioPharma Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.